101 – 110 of 365
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Advancing Basal Insulin Replacement in Type 2 Diabetes Inadequately Controlled With Insulin Glargine Plus Oral Agents: A Comparison of Adding Albiglutide, a Weekly GLP-1 Receptor Agonist, Versus Thrice-Daily Prandial Insulin Lispro.
(
- Contribution to journal › Article
- 2013
-
Mark
Incretin dysfunction in type 2 diabetes: Clinical impact and future perspectives.
(
- Contribution to journal › Scientific review
-
Mark
Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
Methods and Models for Metabolic Assessment in Mice
2013) In Journal of Diabetes Research(
- Contribution to journal › Article
-
Mark
Upregulated insulin secretion in insulin-resistant mice: evidence of increased islet GLP1 receptor levels and GPR119-activated GLP1 secretion.
(
- Contribution to journal › Article
-
Mark
Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials
(
- Contribution to journal › Article
-
Mark
Efficacy and Safety of Lixisenatide Once-Daily Morning or Evening Injections in Type 2 Diabetes Inadequately Controlled on Metformin (GetGoal-M).
(
- Contribution to journal › Article
-
Mark
Shifting the paradigm of islet inflammation-good guy or bad guy?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Glucose-lowering effect of the DPP-4 inhibitor sitagliptin after glucose and non-glucose macronutrient ingestion in non-diabetic subjects.
(
- Contribution to journal › Article
-
Mark
Enhanced beta cell function and anti-inflammatory effect after chronic treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin in an advanced-aged diet-induced obesity mouse model.
(
- Contribution to journal › Article